A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme

Human Reproduction

Volumn 11, Issue 9, 1996, Pages 1864-1870

  Söderström Anttila, Viveca ^a   Foudila, Tuija ^b   Hovatta, Outi ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Vaestoliitto   (Finland)

Author keywords

Efficacy; Highly purified FSH; HMG; Oocyte donation; Tolerability

Indexed keywords

ESTRADIOL; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; UROFOLLITROPIN;

ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFICACY; DRUG SAFETY; EDEMA; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION; HUMAN; INJECTION PAIN; INJECTION SITE; INTRAMUSCULAR DRUG ADMINISTRATION; LUTEINIZING HORMONE BLOOD LEVEL; NORMAL HUMAN; OOCYTE DONATION; OVULATION INDUCTION; PAIN; PREGNANCY RATE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029850204     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019508     Document Type: Article

References (26)

1. Abdalla, H.I., Baber, R., Kirkland, A. et al. (1990) A report on 100 cycles of oocyte donation; factors affecting the outcome. Hum. Reprod., 5, 1018-1022.
2. Abdalla, H.I., Brooks, A.A., Johnson, M.R. et al. (1994) Endometrial thickness: a predictor of implantation in ovum recipients? Hum. Reprod., 9, 363-365.
3. Blanchette, H. (1993) Obstetric performance of patients after oocyte donation. Am. J. Obstet. Gynecol., 168, 1803-1807.
4. Chappel, S.C. and Howles, C. (1991) Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum. Reprod., 6, 1206-1212.
5. Chong, A.P., Rafael, R.W. and Forte, C.C. (1986) Influence of weight in the induction of ovulation with human menopausal gonadotropin and human chorionic gonadotropin. Fertil. Steril., 46, 599-603.
6. le Cotonnec, J.-Y., Porchet, H. C., Beltrami, V. and Howles, C. (1993) Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers. Hum. Reprod., 8, 1604-1611.
7. Daya, S.M.B., Gunby, J., Hughes, E.G. et al. (1995a) Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis. Fertil. Steril., 64, 347-354.
8. Daya, S.M.B., Gunby, J., Hughes, E.G. et al. (1995b) Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in-vitro fertilization. Hum. Reprod., 10, 1392-1396.
9. Dewhurst, J. (1981) Integrated Obstetrics and Gynaecology for Postgraduates, 3rd edn. Blackwell Scientific, Oxford.
10. Edwards, R.G., Morcos, S., Macnamee, M. et al. (1991) High fecundity of amenorrhoeic women in embryo-transfer programmes. Lancet, 338, 292-294.
11. Halme, J., Toma, S.K. and Talbert, L.M. (1995) A case of severe ovarian hyperstimulation in a healthy oocyte donor. Fertil. Steril., 64, 857-859.
12. Howles, C.M., Loumaye, E., Giroud, D. and Luyet, G. (1994) Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: a multicentre European phase III study. Hum. Reprod., 9, 424-430.
13. Irvine, R., Korea, L., Latarche, E. et al. (1995) A randomised assessor blind group comparative study comparing high purity Metrodin and Pergonal in 100 women undergoing superovulation for egg donation. Annual Meeting of American Society for Reproductive Medicine 1995, Abstract 202.
14. Lambert, A., Rodgers, M, Mitchell, R. et al. (1995) In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP. Hum. Reprod., 10, 1928-1935.
15. Legro, R.S., Wong, I.L., Paulson, R.J. et al. (1995) Multiple implantation after oocyte donation: a frequent but inefficient event. Fertil. Steril., 63, 849-853.
16. Li, T.C. and Hindle, J.E. (1993) Adverse local reaction to intramuscular injections of urinary-derived gonadotrophins. Hum. Reprod., 8, 1835-1836.
17. McClure, N., McQuinn B., McDonald, J. et al. (1992) Body weight, body mass index, and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome? Fertil. Steril., 58, 622-624.
18. Out, H.J., Mannaerts, M.J.L., Driessen, S.G.A.J. and Coelingh Bennink, H.J.T. (1995) A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum. Reprod., 10, 2534-2540.
19. Pados, G., Camus, M., Van Steirteghem, A. et al. (1994) The evolution and outcome of pregnancies from oocyte donation. Hum. Reprod., 9, 538-542.
20. Sauer, M.V. and Paulson, R.J. (1994) Mishaps and misfortunes: complications that occur in oocyte donation. Fertil. Steril., 61, 963-965.
21. Scott, R.T., Hofmann, G.E., Veeck, L.L. et al. (1991) Embryo quality and pregnancy rates in patients attempting pregnancy through in vitro fertilization. Fertil. Steril., 55, 426-428.
22. Serhal, P.F. and Craft, I. (1987) Immune basis for pre-eclampsia: evidence from oocyte recipients. Lancet, ii, 744.
23. Sokal, R.R. and Rohlf, F.J. (1995) Biometry, 3rd edn, W.H.Freeman and Company, New York, USA.
24. Söderström-Anttila, V. and Hovatta, O. (1995) An oocyte donation program with goserelin down-regulation of voluntary donors. Acta Obstet. Gynecol. Scand., 74, 288-292.
25. Tapanainen, J., Hovatta, O., Juntunen, K. et al. (1993) Subcutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF: a randomized comparative study. Hum. Reprod., 8, 2052-2055.
26. Wikland, M., Borg, J., Hamberger, L. and Svalander, P. (1994) Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction. Hum. Reprod., 9, 1430-1436.